{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Immunome, Inc."},"Symbol":{"label":"Symbol","value":"IMNM"},"Address":{"label":"Address","value":"665 STOCKTON DRIVE,SUITE 300, EXTON, Pennsylvania, 19341, United States"},"Phone":{"label":"Phone","value":"+1 610 321-3700"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19."},"CompanyUrl":{"label":"Company Url","value":"https://www.immunome.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bob Lechleider","title":"Chief Medical Officer"},{"name":"Clay B. Siegall","title":"Chairman, President & Chief Executive Officer"},{"name":"Jack Higgins","title":"Chief Scientific Officer"},{"name":"Max Rosett","title":"CFO, Chief Accounting Officer & EVP-Operations"},{"name":"Philip Tsai","title":"Chief Technical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}